Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation

Vaccine

Volumn 24, Issue 13, 2006, Pages 2367-2376

  Platonov, A E ^a   Griffiths, U K ^b   Voeykova, M V ^a   Platonova, O V ^a   Shakhanina, I L ^a,c   Chistyakova, G G ^c   Robertson, S E ^b  

^a Central Research Institute of Epidemiology   (Russian Federation)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Sanitary and Epidemiological Surveillance of the Russian Federation   (Russian Federation)

Author keywords

Economic evaluation; Haemophilus influenzae type b vaccine; Meningitis; Russian Federation

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE;

ARTICLE; BACTERIAL MENINGITIS; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DRUG COST; HAEMOPHILUS INFLUENZAE; HOSPITAL CHARGE; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RATE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SENSITIVITY ANALYSIS;

CHILD; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; HAEMOPHILUS VACCINES; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFANT; MENINGITIS, HAEMOPHILUS; POLYSACCHARIDES, BACTERIAL; PROSPECTIVE STUDIES; RUSSIA; VACCINATION;

EID: 33344456658     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2005.11.054     Document Type: Article

References (60)

1. Bennett JV, Platonov AE, Slack MPE, Mala P, Burton AH, Robertson SE. Haemophilus influenzae type b (Hib) meningitis in the pre-vaccine era: a global review of incidence, age distributions, and case-fatality rates. Document WHO/V&B/02.18. Geneva: World Health Organization, 2002.
2. United Nations. World economic and social survey, 2003. New York: United Nations, 2003.
3. N.P. Deviatkina, T.V. Il'ina, I.S. Koroleva, I.V. Martynov, and A.A. Demina [The characteristics of suppurative meningitis morbidity caused by Streptococcus pneumoniae and Haemophilus influenzae type b] Zh Microbiol Epidemiol Immunobiol 1 1990 45 49 (in Russian)
4. A.A. Diomina, L.V. Spirikhina, I.S. Koroliova, and M.O. Volkova Childhood Haemophilus influenzae type b meningitis in Russia Eur J Pediatr 158 1 1999 85
5. I.S. Koroleva, A.A. Demina, A.E. Platonov, G.V. Beloshizkii, A.M. Gracheva, and L.V. Spririkhina [Epidemiologic surveillance of bacterial meningitis: twenty years of studies] Epidemiol Vaccine Prevent 5 12 2003 10 13 (in Russian)
6. Platonov AE, Koroleva IS, Platonova OV, Samsonova IM, Gracheva AM, Sprikhina LV, et al. [Population-based surveillance of Haemophilus influenzae type b infection in children <5 years of age in Moscow]. In: Proceedings of the VIII Russian Congress of Epidemiologists, Microbiologists, and Parasitologists, vol. 1. Moscow: Roseneks Publisher, 2002. p. 88-9 (in Russian).
7. Yu.Ya. Vengerov, A.E. Platonov, M.V. Voyekova, I.S. Koroleva, A.P. Bogatyreva, and G.V. Kruchkova [Hib meningitis: clinical findings, diagnosis, and treatment] Physician 1-2 2002 72 77 (in Russian)
8. E.N. Tyutyunnik, Yu.Ya. Vengerov, G.A. Shipulin, O.Y. Shipulina, and A.E. Platonov [Evaluation of PCR effectiveness for diagnosis of purulent bacterial meningitis] Ann Metchnikov Institut 1 2001 75 76 (in Russian)
9. A.E. Platonov, K.O. Mironov, S.B. Yazyshina, I.S. Koroleva, O.V. Platonova, and A.E. Guzshin Characteristics of Moscow strains of Haemophilus influenzae type b by multilocus sequence typing Mol Gen Mikrobiol Virusol 3 2003 18 25
10. FXHistory: historical currency exchange rates. http://www.oanda.com/ convert/fxhistory. Accessed: 12 January, 2005.
11. M.F. Drummond, M.J. Sculpher, G.W. Torrance, B.J. O'Brien, and G.L. Stoddart Methods for the economic evaluation of health care programmes 3rd ed. 2005 Oxford Medical Publications, Oxford University Press
12. Levine OS, Schuchat A, Schwartz B, Wenger JD, Elliott J. Generic protocol for population-based surveillance of Haemophilus influenzae type b. Document WHO/VRD/GEN/95.05. Geneva: World Health Organization, 1995.
13. Popovic T, Ajello G, Facklam R, Caugnant D, Nicolas P, Perkins B, et al. Laboratory manual for the diagnosis of meningitis caused by Neisseria meningiditis, Streptococcus pneumoniae and Haemophilus influenzae. Document WHO/CDS/CSR/EDC/99.7. Geneva: World Health Organization, 1999.
14. Onishenko GG. Letter No. 2510/10099-97-32 of 30 December 1997 from Ministry of Public Health concerning prevention of Hib infection. Reprinted in: Vaccination [Vakzinazia] 2003;2(26):7-8.
15. Kou UK. Guidelines for estimating costs of introducing new vaccines into the national immunization system. Document WHO/V&B02.11. Geneva: World Health Organization, 2002.
16. WHO, Immunization financing. http://www.who.int/immunization_financing/ en. Accessed: 30 November 2004.
17. "MEDARGO" Pharmaceutical Company. http://www.helm.medargo.ru/ tovar/price.htm. Accessed: 27 November 2004.
18. Formed. Price list for Aventis Pasteur vaccines. http://www.formed.ru/ aven-prais.htm (in Russian). Accessed: 25 November 2004.
19. P.T. Heath Haemophilus influenzae type b conjugate vaccines: a review of efficacy data Pediatr Infect Dis J 17 Suppl. 9 1998 S117 S122
20. UNICEF Supply Division. Vaccine projections for 2004. http://www.unicef.org/supply/index_7991.html. Accessed: 26 November 2004.
21. Expanded Programme on Immmunization in the Americas. PAHO's Revolving Fund vaccine prices for 2004. EPI Newslett 2004;24(1):7-8.
22. Centers for Disease Control and Prevention. CDC Vaccine price list, last updated 26 August 2004. http://www.gov/nip/cdc_vac_price_list.pdf. Accessed: 26 November 2004.
23. United Nations Population Division. World population prospects, 2002 revision. Volume 1: Comprehensive Tables. New York: United Nations, 2003.
24. I.L. Shakhanina, I.M. Samsonova, A.A. Demina, M.N. Sorokina, and N.V. Skriptchenko [Economic expenditures related to purulent bacterial meningitis caused by Haemophilus influenzae type b in Russia] Epidemiol Infect Dis 3 1999 21 24 (in Russian)
25. C.J.L. Murray A.D. Lopez The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020 1996 Harvard School of Public Health Boston
26. C. Pritchard, and M. Sculpher Productivity costs: principles and practice in economic evaluation. 2000 Office of Health Economics London
27. Russian Statistical Bulletin, 2001. Moscow: Goskomstat, 2001.
28. H. Peltola Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of polysaccharide vaccine and a decade after the advent of conjugates Clin Microbiol Rev 13 2 2000 302 317
29. D.A. Clements Cost of treatment and prevention of Haemophilus influenzae type b disease: an international perspective Pharmacoeconomics 6 5 1994 442 452
30. R. Brinsmead, S. Hill, and D. Walker Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines Pediatr Infect Dis J 23 1 2004 32 37
31. Hutubessy R, Khurieva N, Vinokur A, Dye C, Floyd K. The cost and cost-effectiveness of tuberculosis control in the Russian Federation. IUATLD conference abstract, 23-25 June 2004. Moscow, Russian Federation.
32. Khurieva N, Hutubessy RCW, Peremitin G, Barry D, Jakubowiak W, Floyd K. Cost-effectiveness evaluation of DOTS Plus Programme in Tomsk Oblast. IUATLD conference abstract, 23-25 June 2004. Moscow, Russian Federation.
33. WHO, Choosing interventions that are cost-effective (CHOICE). http://www.who.int/evidence/cea. Accessed: 7 December 2004.
34. M. Kojouharova, N. Gatcheva, L. Setchanova, S.E. Robertson, J.D. Wenger the Bulgarian Hib Study Team Epidemiology of meningitis due to Haemophilus influenzae type b in children in Bulgaria: a prospective, population-based surveillance study Bull World Health Org 80 9 2002 690 695
35. C. Severien, and T.H. Lehners Epidemiology of invasive Haemophilus influenzae disease in a German city Klin Padiatr 206 2 1994 108 111
36. M.N. Tsolia, M.N. Theodoridou, G.J. Mostrou, I.I. Paraskaki, A.M. Pangali, and A.S. Yelesme Epidemiology of invasive Haemophilus influenzae type b infections among children in Greece before the introduction of immunization Scand J Infect Dis 30 2 1998 165 168
37. A. Zielinski, J. Tomaszunas-Blaszczyk, and D. Kuklinska Epidemiology of childhood bacterial meningitis in Poland Eur J Epidemiol 17 8 2001 779 782
38. V. Luca, B.D. Gessner, C. Luca, T. Turcu, S. Rugina, and C. Rugina Incidence and etiological agents of bacterial meningitis among children <5 years in two districts of Romania Eur J Clin Microbiol Infect Dis 23 7 2004 523 528
39. A. Zielinski, C.B. Kwon, J. Tomaszunas-Blaszczyk, W. Magdzik, and J.V. Bennett Risk of Haemophilus influenzae type b meningitis in Polish children varies directly with number of siblings: possible implications for vaccination strategies Eur J Epidemiol 18 9 2003 917 922
40. A.K. Takala, J. Escola, J. Palmgren, P.R. Ronnberg, E. Kela, and P. Rekola Risk factors of invasive Haemophilus influenzae type b disease among children in Finland J Pediatr 115 5 Pt. 1 1989 694 701
41. D.A. Clements, R. Booy, R. Dagan, G.L. Gilbert, E.R. Moxon, and MP.E. Slack Comparison of the epidemiology and cost of Haemophilus influenzae type b disease in five western countries Pediatr Infect Dis J 12 5 1993 362 367
42. L.J. Baraff, S.I. Lee, and D.L. Schriger Outcomes of bacterial meningitis in children: a meta-analysis Pediatr Infect Dis J 12 5 1993 389 394
43. O.S. Levine, E. Ortiz, R. Contreras, R. Lagos, P. Vial, and A. Misraji Cost-benefit analysis for the use of Haemophilus influenzae type b conjugates vaccine in Santiago, Chile Am J Epidemiol 137 11 1993 1221 1228
44. O. Garpenholt, S.A. Silfverdal, and L.A. Levin Economic evaluation of general childhood vaccination against Haemophilus influenzae type b in Sweden Scand J Infect Dis 30 1 1998 5 10
45. A. Livartowski, J. Boucher, B. Detournay, and P. Reinert Cost-effectiveness evaluation of vaccination against Haemophilus influenzae invasive diseases in France Vaccine 114 6 1996 495 500
46. B. Trollfors Cost-benefit analysis of general vaccination against Haemophilus influenzae type b in Sweden Scand J Infect Dis 26 5 1994 611 614
47. E.J. Jiminez, P. Buallar-Castillon, C.R. Terres, and E. Buallar Cost-benefit analysis of Haemophilus influenzae type b vaccination in children in Spain Pharmacoeconomics 15 1 1999 75 83
48. A. Harris, D. Hendrie, C. Bower, J. Payne, N. de Klerk, and F. Stanley The burden of Haemophilus influenzae type b disease in Australia and an economic appraisal of the vaccine PRP-OMP Med J Austral 160 8 1994 483 488
49. P. McIntyre, J. Hall, and S. Leeder An economic analysis of alternatives for childhood immunization against Haemophilus influenzae type b disease Aust J Public Health 18 4 1994 394 400
50. F. Zhou, K.M. Bisgard, H.R. Yusuf, R.R. Deuson, S.K. Bath, and T.V. Murphy Impact of universal Haemophilus influenzae type b vaccination starting at 2 months of age in the United States: an economic analysis Pediatrics 110 4 2002 653 661
51. G.M. Ginsberg, I. Kassis, and R. Dagan Cost benefit analysis of Haemophilus influenzae type b vaccination programme in Israel J Epidemiol Community Health 47 6 1993 485 490
52. T. Duke Haemophilus influenzae type b meningitis: how much better is prevention than cure PNG Med J 45 3-4 2002 213 218
53. I.H.M. Hussain, S. Aljunid, A. Sofiah, L.C. Ong, K.E. Choo, and M.N. Musa Cost-benefit analysis of Haemophilus influenzae vaccination programme in Malaysia Buletin Kesihatan Masyarakat Jilid 5 1999 79 89
54. G.D. Hussey, M.L. Lasser, and W.D. Reekie The costs and benefits of a vaccination programme for Haemophilus influenzae type b disease S Afr Med J 85 1 1995 20 25
55. M.R.M.T. Limcangco, C.L. Armour, E.G. Salole, and S.J. Taylor Cost-benefit analysis of a Haemophilus influenzae type b meningitis prevention programme in the Philippines Pharmacoeconomics 19 4 2001 391 400
56. M. Pokorn, S. Kopac, D. Neubauer, and M. Cizman Economic evaluation of Haemophilus influenzae type b vaccination in Slovenia Vaccine 19 25-26 2001 3600 3605
57. WHO, The World Health Report 2002 - Reducing Risks, Promoting Healthy Lives, Geneva, 2002.
58. World Bank, International Comparison Programme, www.worldbank.org/data/ databytopic/GNIPC.pdf. Accessed: 19 September 2005.
59. Zurabov M, Russian Minister of Public Health. http://www.mednovosti.ru/ news/2005/09/07/zurabov. Accessed: 10 September 2005.
60. B.D. Gessner, A. Sutanto, M. Linehan, I.G. Djelantik, T. Fletcher, and I.K. Gerudug Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial Lancet 365 9453 2005 43 52